drugset / Trial / NCT00243750
Methotrexate in Ankylosing Spondylitis (MTX in AS)
Non-randomizedSingle-groupOpen-labelEct
Summary
Assessing the efficacy and tolerability of methotrexate 15mg sc in the first month of treatment- if well tolerated methotrexate 20mg sc in the following 3 months in patients with active anklyosing spondylitis
Timeline
- Start
- 2003-09
- Primary completion
- —
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 20 mg | Subcutaneous |